A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors
Dyk ned i forskningsemnerne om 'A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors'. Sammen danner de et unikt fingeraftryk.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science